超声引导下微波消融治疗原发性甲状旁腺功能亢进症1例并文献复习

doi:10.3969/j.issn.1004-583X.2021.06.014

摘要/Abstract

摘要：

原发性甲状旁腺功能亢进症(甲旁亢)是内分泌系统的常见疾病之一,传统治疗方案包括手术治疗和药物治疗。外科手术虽然是首选的治疗手段,但部分患者可能存在手术禁忌证或者由于各种因素拒绝手术,药物治疗亦无法从根本上去除病因故疗效欠佳,因此探索微创手段治疗原发性甲旁亢具有重要的临床意义。微波消融技术曾用于良恶性甲状腺结节、继发性甲旁亢及其他部位肿瘤的治疗,并取得了一定疗效,本文报道采用超声引导下微波消融治疗原发性甲旁亢1例,系统记录了该患者的诊疗、随访经过,并结合文献分析了微波消融治疗原发性甲旁亢的随访观察要点。

关键词: 甲状旁腺功能亢进, 原发性, 微波消融, 骨代谢

Abstract:

Primary hyperparathyroidism(pHPT) is a common endocrine disease. The traditional treatment modalities of it include operative treatment and drug therapy. Though the former is the preferred treatment, some patients refuse this modality because of possibly operational contraindications or other reasons. Drug treatment cannot eradicate the disease and has poor efficacy. Therefore, it is significant to explore the application of minimally invasive technique in the treatment of pHPT. Microwave ablation (MWA) has been used in the treatment of benign and malignant thyroid nodules, secondary HPT and other tumors, and has had certain efficacy. This paper reports a pHPT case treated with ultrasound-guided percutaneous MWA, systematically records the diagnosis, treatment and follow-up process. And the key points of follow-up observation are analyzed with literature review.

Key words: Hyperparathyroidism, Primary, microwave ablation, bone metabolism

中图分类号:

R582.1

杨静, 田永峰, 瞿华. 超声引导下微波消融治疗原发性甲状旁腺功能亢进症1例并文献复习[J]. 临床荟萃, 2021, 36(6): 548-551.

Yang Jing, Tian Yongfeng, Qu Hua. Ultrasound-guided percutaneous microwave ablation for primary hyperparathyroidism: a case report and literature review[J]. Clinical Focus, 2021, 36(6): 548-551.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2021.06.014

https://huicui.hebmu.edu.cn/CN/Y2021/V36/I6/548

图/表 2

参考文献 16

[1]	Fraser WD. Hyperparathyroidism[J]. Lancet, 2009, 374(9684):145-158. doi: 10.1016/S0140-6736(09)60507-9 URL
[2]	Farford B, Presutti RJ, Moraghan TJ. Nonsurgical management of primary hyperparathyroidism[J]. Mayo Clin Proc, 2007, 82(3):351-355. pmid: 17352371
[3]	Han Y, Shao N, Xi X, et al. Use of microwave ablation in the treatment of patients with multiple primary malignant tumors[J]. Thorac Cancer, 2017, 8(4):365-371. doi: 10.1111/tca.2017.8.issue-4 URL
[4]	Liang P, Gao Y, Zhang H, et al. Microwave ablation in the spleen for treatment of secondary hypersplenism: A preliminary study[J]. AJR Am J Roentgenol, 2011, 196(3):692-696. doi: 10.2214/AJR.10.4193 URL
[5]	Wang Y, Liang P, Yu X, Cheng Z, Yu J, Dong J. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: Preliminary results[J]. Int J Hyperthermia, 2009, 25(6):455-461. doi: 10.1080/02656730903066608 URL
[6]	Wei Z, Ye X, Yang X, et al. Advanced non small cell lung cancer: Response to microwave ablation and EGFR Status[J]. Eur Radiol, 2017, 27(4):1685-1694. doi: 10.1007/s00330-016-4474-4 URL
[7]	Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: Present and future perspectives[J]. AJR Am J Roentgenol, 2012, 199(5):1164-1168. doi: 10.2214/AJR.11.8442 URL
[8]	葛明华, 徐栋, 杨安奎等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版)[J]. 中国肿瘤, 2018, 27(10):768-773.
[9]	Liu C, Wu B, Huang P, et al. US-guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: Feasibility and safety study[J]. J Vasc Interv Radiol, 2016, 27(6):867-875. doi: 10.1016/j.jvir.2016.02.013 URL
[10]	Varma R, Kim YJ, Garjian K, et al. Hyperparathyroidism and hungry bone syndrome revisited[J]. Clin Nucl Med, 2014, 39(8):704-706. doi: 10.1097/RLU.0000000000000500 URL
[11]	Malabu UH, Founda MA. Primary hyperparathyroidism in Saudi Arabia: A review of 46 cases[J]. Med J Malaysia, 2007, 62(5):394-397.
[12]	Yang G, Zha X, Mao H, et al. Hypocalcemia-based prediction of hungry bone syndrome after parathyroidectomy in hemodialysis patients with refractory secondary hyperparathyroidism[J]. J Int Med Res, 2018, 46(12):4985-4994. doi: 10.1177/0300060518788744 URL
[13]	Carty SE, Roberts MM, Virji MA, et al. Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism[J]. Surgery, 2002, 132(6):1086-1092. doi: 10.1067/msy.2002.128479 URL
[14]	Goldfarb M, Gondek S, Irvin GL, et al. Normocalcemic parathormone elevation after successful parathyroidectomy: Long-term analysis of parathormone variations over 10 years[J]. Surgery, 2011, 150(6):1076-1084. doi: 10.1016/j.surg.2011.09.017 URL
[15]	Beyer TD, Solorzano CC, Prinz RA, et al. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism[J]. Surgery, 2007, 141(6):777-783. doi: 10.1016/j.surg.2007.01.025 URL
[16]	原发性甲状旁腺功能亢进症诊疗指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2014, 7(3):187-198.